
Notes will be issued on the 1st of March 2025 and run for 12 months with new issuances on the 1st of each month. Funds invested will qualify to be included in the next issuance provided that funds are received before the 25th of the preceding month. The simple interest of 9% per
annum will accrue monthly but be capitalized annually. Interest accrues and is not paid out as dividends until redemption, which will occur anytime thereafter with 90 days' notice. There is however a 1-year lock-in period. The full value of the capital and accrued interest will be paid into the investors’ wallet 14 days after the end of the month following redemption. Once funds are reflected in the investor’s wallet, they are available for immediate withdrawal or reinvestment.
Security and Collateral
The AccretivPLUS TI Note is backed by a medical commercial real estate portfolio exceeding $200 million in value with over $80 million invested equity, providing investors with structured risk-adjusted returns in a resilient asset class.